158 related articles for article (PubMed ID: 6766838)
1. Antimicrobial agents for immune compromised patients.
Al-Sawwaf M; Pancoast SJ; Hardy MA; Appel GB
Compr Ther; 1980 Jan; 6(1):18-26. PubMed ID: 6766838
[No Abstract] [Full Text] [Related]
2. [Infectious disease in immunologic deficiency].
Kitamoto O
Naika; 1972; 29(2):291-4. PubMed ID: 5015102
[No Abstract] [Full Text] [Related]
3. Infections in the immunocompromised host.
Solberg CO
Scand J Infect Dis Suppl; 1980; Suppl 24():36-43. PubMed ID: 6782661
[No Abstract] [Full Text] [Related]
4. Antimicrobial therapy in the myelo- and immuno-compromised patient.
van den Broek PJ; van der Meer JW
Neth J Med; 1979; 22(4):118-22. PubMed ID: 113688
[No Abstract] [Full Text] [Related]
5. [Possibilities and limits for preventing infections in persons with a cellular immunity deficit].
Teodorovici G
Rev Med Chir Soc Med Nat Iasi; 1986; 90(1):14-8. PubMed ID: 3094113
[No Abstract] [Full Text] [Related]
6. The management of infections in the hematologically compromised patient.
Schwob MF
Pediatr Ann; 1977 Dec; 6(12):778-85. PubMed ID: 304203
[No Abstract] [Full Text] [Related]
7. Experience with protective isolation for infection prevention in the compromised host.
Nagao T
Tokai J Exp Clin Med; 1986; 11 Suppl():23-8. PubMed ID: 3132751
[TBL] [Abstract][Full Text] [Related]
8. Infections in the elderly--new developments.
Crossley K; Peterson PK
Curr Clin Top Infect Dis; 1998; 18():75-100. PubMed ID: 9779352
[No Abstract] [Full Text] [Related]
9. [Therapy of pneumonia caused by unknown pathogens].
Kitahara M
Nihon Naika Gakkai Zasshi; 1991 May; 80(5):730-2. PubMed ID: 1875109
[No Abstract] [Full Text] [Related]
10. [Therapeutic protocols of pneumonia in children].
Cobos Barroso N
An Esp Pediatr; 1988 Sep; 29 Suppl 33():222-32. PubMed ID: 3074709
[No Abstract] [Full Text] [Related]
11. [Immunologic deficiencies].
Peters A; Hervé P
Sem Hop; 1973 May; 49(25):1845-7. PubMed ID: 4127415
[No Abstract] [Full Text] [Related]
12. Infection in immunocompromised patients.
Geddes AM; Ellis CJ
Q J Med; 1985 Apr; 55(216):5-14. PubMed ID: 4011843
[TBL] [Abstract][Full Text] [Related]
13. The compromised host. Deficit-specific infection and the spectrum of prevention.
Gurevich I; Tafuro P
Cancer Nurs; 1986 Oct; 9(5):263-75. PubMed ID: 3096553
[No Abstract] [Full Text] [Related]
14. The choice of systemic antimicrobial drugs.
Med Lett Drugs Ther; 1968 Oct; 10(20):77-84. PubMed ID: 5731799
[No Abstract] [Full Text] [Related]
15. Lethal infections associated with severe burns.
Brown M; Deitch EA
Compr Ther; 1990 Aug; 16(8):42-7. PubMed ID: 2122938
[No Abstract] [Full Text] [Related]
16. [Common infections in immunocompromised patients].
Malinverni R
Schweiz Med Wochenschr; 1987 May; 117(18):669-75. PubMed ID: 3589624
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of infections in primary immunodeficiency syndromes].
Kajiwara M; Yata J
Nihon Rinsho; 1990 Oct; 48(10):2347-54. PubMed ID: 1704073
[No Abstract] [Full Text] [Related]
18. The choice of systemic antimicrobial agents.
Med Lett Drugs Ther; 1965 Oct; 7(21):81-8. PubMed ID: 5827276
[No Abstract] [Full Text] [Related]
19. [Nervous system infections in immunosuppression].
Martínez-Martín P; Estévez E; Rapun JL
Rev Sanid Hig Publica (Madr); 1985; 59(7-8):851-61. PubMed ID: 3832368
[No Abstract] [Full Text] [Related]
20. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.
Micek ST; Kollef KE; Reichley RM; Roubinian N; Kollef MH
Antimicrob Agents Chemother; 2007 Oct; 51(10):3568-73. PubMed ID: 17682100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
